The Paradox of Pharmaceutical Profit and Public Health Decline

This chapter explores the troubling financial triumph of the pharmaceutical industry in the face of declining health outcomes, such as increasing suicide rates and obesity. It critiques the emphasis on profit-driven drug development that prioritizes marketability over health improvement, while examining the impact of advertising, regulatory immunity, and media complicity.